Multidisciplinary management of childhood brain tumors: A review of outcomes, recent advances, and challenges - A review

Journal of Neurosurgery: Pediatrics

Volumn 8, Issue 2, 2011, Pages 135-148

  Pollack, Ian F ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Astrocytoma; Brain tumor; Ependymoma; Medulloblastoma; Molecular markers; Oncology

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CISPLATIN; ETOPOSIDE; EVEROLIMUS; GADOLINIUM TEXAPHYRIN; GEFITINIB; HISTONE DEACETYLASE INHIBITOR; IMATINIB; ISOTRETINOIN; LENALIDOMIDE; LOMUSTINE; METHOTREXATE; PROCARBAZINE; TEMOZOLOMIDE; TIOGUANINE; TIPIFARNIB; VINBLASTINE; VINCRISTINE; VISMODEGIB; VORINOSTAT;

ASTROCYTOMA; BRAIN STEM GLIOMA; BRAIN SURGERY; BRAIN TUMOR; CANCER GROWTH; CANCER SURVIVAL; CHILDHOOD CANCER; EPENDYMOMA; GIANT CELL ASTROCYTOMA; GLIOMA; HIG GRADE GLIOMA; HIGH GRADE GLIOMA; HUMAN; LOW GRADE GLIOMA; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; NEUROFIBROMATOSIS; PONTINE GLIOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVIEW; TREATMENT OUTCOME;

BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; GLIOMA; HUMANS; MEDICAL ONCOLOGY; MEDULLOBLASTOMA; PATIENT CARE TEAM; PEDIATRICS;

EID: 79961119714     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2011.5.PEDS1178     Document Type: Review

References (124)

1. Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD: Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neurosurgery 33:1026-1030, 1993 (Pubitemid 23358397)
2. Ashley DM, Lyon N, Bonner M, Msall M, Zhou T, Strother D, et al: Developmental and functional outcome following post-operative chemotherapy and local conformal radiation in infants with medulloblastoma using a centrally administered phone based interview technique, follow up report: a Children's Oncology Group study. Neuro Oncol 12:ii9, 2010 (Abstract)
3. Ashley DM, Merchant TE, Zhou T, Geyer R, Pollack IE, Duffner PK, et al: Systemic chemotherapy, second look surgery and conformal radiation therapy limited to the posterior fossa and primary site for children > 8 months and < 3 years with nonmetastatic medulloblastoma: a Children's Oncology Group phase III study, follow up report. Neuro Oncol 12:ii6, 2010 (Abstract)
4. Ater J, Holmes E, Zhou T, Mazewski C, Roberts W, VezinaG, et al: Results of COG protocol A9952: a randomized phase 3 study of two chemotherapy regimens for incompletely resected low-grade glioma in young children. Neuro Oncol 10:451-452, 2008 (Abstract)
5. Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, et al: Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297:1559-1561, 2002 (Pubitemid 34971004)
6. Bernier-Chastagner V, Grill J, Doz F, Bracard S, Gentet JC, Marie-Cardine A, et al: Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer 104:2792-2797, 2005 (Pubitemid 41798290)
7. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B: Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74-79, 1999 (Pubitemid 29062960)
8. Bradley KA, Pollack IF, Reid JM, Adamson PC, Ames MM, Vezina G, et al: Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study. Neuro Oncol 10:752-758, 2008
9. Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, et al: Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27:385-389, 2009
10. Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E, et al: Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. Neuro Oncol 13:410-416, 2011
11. Cohen KJ, Pollack IF, Zhou T, Buxton A, Holmes EJ, Burger PC, et al: Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol 13:317-323, 2011
12. Dhall G, Grodman H, Ji L, Sands S, Gardner S, Dunkel IJ, et al: Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols. Pediatr Blood Cancer 50:1169-1175, 2008 (Pubitemid 351555540)
13. Due-Tønnessen BJ, Helseth E, Scheie D, Skullerud K, Aamodt G, Lundar T: Long-term outcome after resection of benign cerebellar astrocytomas in children and young adults (0-19 years): report of 110 consecutive cases. Pediatr Neurosurg 37:71-80, 2002 (Pubitemid 34977955)
14. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, et al: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725-1731, 1993 (Pubitemid 23170121)
15. Dunkel IJ, Garvin JH Jr, Goldman S, Ettinger LJ, Kaplan AM, Cairo M, et al: High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. J Neurooncol 37:67-73, 1998 (Pubitemid 28073577)
16. Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA: Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 56:7-15, 2011
17. Ellenberg L, McComb JG, Siegel SE, Stowe S: Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 21:638-644, 1987 (Pubitemid 18001501)
18. Epstein F, McCleary EL: Intrinsic brain-stem tumors of childhood: surgical indications. J Neurosurg 64:11-15, 1986 (Pubitemid 16189592)
19. Evans AE, Jenkin RDT, Sposto R, Ortega JA, Wilson CB, Wara W, et al: The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572-582, 1990 (Pubitemid 20113683)
20. Finkelstein-Shechter T, Gassas A, Mabbott D, Huang A, Bartels U, Tabori U, et al: Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol 32:e182-e186, 2010
21. Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, et al: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. J Clin Oncol 13:112-123, 1995
22. Fisher BJ, Leighton CC, Vujovic O, Macdonald DR, Stitt L: Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas. Int J Radiat Oncol Biol Phys 51:704-710, 2001
23. Freeman CR, Krischer JP, Sanford RA, Cohen ME, Burger PC, del Carpio R, et al: Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 27:197-206, 1993 (Pubitemid 23304443)
24. Garrè ML, Cama A, Bagnasco F, Morana G, Giangaspero F, Brisigotti M, et al: Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome - a new clinical perspective. Clin Cancer Res 15:2463-2471, 2009
25. Garvin J, Sposto R, Stanley P, Rorke L, Packer R: Childhood ependymoma: improved survival for patients with incompletely resected tumors with the use of preirradiation chemotherapy. Neuro Oncol 6:456, 2004 (Abstract)
26. Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD, Hammond GD: Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial. Cancer 66:2465-2469, 1990
27. Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, et al: Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol 23:7621-7631, 2005 (Pubitemid 46291826)
28. Geyer JR, Stewart CF, Kocak M, Broniscer A, Phillips P, Douglas JG, et al: A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas. Eur J Cancer 46:3287-3293, 2010
29. Grill J, Sainte-Rose C, Jouvet A, Gentet JC, Lejars O, Frappaz D, et al: Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol 6:573-580, 2005 (Pubitemid 41051935)
30. Gururangan S, Chi SN, Young Poussaint T, Onar-Thomas A, Gilbertson RJ, Vajapeyam S, et al: Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. J Clin Oncol 28:3069-3075, 2010
31. Haas-Kogan DA, Banerjee A, Poussaint TY, Kocak M, Prados MD, Geyer JR, et al: Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro Oncol 13:298-306, 2011
32. Hales RK, Shokek O, Burger PC, Paynter NP, Chaichana KL, Quiñones-Hinojosa A, et al: Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis. J Neurooncol 99:65-71, 2010
33. Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP, et al: BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med 9:1033-1038, 2003 (Pubitemid 37021783)
34. Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, et al: Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 118:469-474, 2009
35. Hirsch JF, Sainte Rose C, Pierre-Kahn A, Pfister A, Hoppe- Hirsch E: Benign astrocytic and oligodendrocytic tumors of the cerebral hemispheres in children. J Neurosurg 70:568-572, 1989 (Pubitemid 19100717)
36. Horbinski C, Hamilton RL, Nikiforov Y, Pollack IF: Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas. Acta Neuropathol 119:641-649, 2010
37. Horn B, Heideman R, Geyer R, Pollack I, Packer R, Goldwein J, et al: A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol 21:203-211, 1999 (Pubitemid 30306031)
38. Hukin J, Epstein F, Lefton D, Allen J: Treatment of intracranial ependymoma by surgery alone. Pediatr Neurosurg 29:40-45, 1998 (Pubitemid 29060798)
39. Jakacki R, Burger P, Zhou T, Holmes E, Packer R, Goldwein J, et al: Outcome for metastatic (M+) medulloblastoma (MB) treated with carboplatin during craniospinal radiotherapy (CSRT) followed by cyclophosphamide (CPM) and vincristine (VCR): preliminary results of COG 99701. J Clin Oncol 25 (Suppl):75S, 2007 (Abstract)
40. Jakacki RI, Burger P, Zhou T, Buxton A, Cohen K, Rosenblum M, et al: A phase II study of concurrent radiation and temozolomide (TMZ) followed by temozolomide and lomustine (CCNU) in the treatment of children with high grade glioma (HGG): results of COG ACNS0423. Neuro Oncol 12:ii12, 2010 (Abstract)
41. Jakacki RI, Yates A, Blaney SM, Zhou T, Timmerman R, Ingle AM, et al: A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood. Neuro Oncol 10:569-576, 2008
42. Jenkin RDT, Boesel C, Ertel I, Evans A, Hittle R, Ortega J, et al: Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group. J Neurosurg 66:227-233, 1987 (Pubitemid 17027880)
43. Jennings MT, Sposto R, Boyett JM, Vezina LG, Holmes E, Berger MS, et al: Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group. J Clin Oncol 20:3431-3437, 2002
44. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, et al: Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466:632-636, 2010
45. Jones DT, Kocialkowski S, Liu L, Pearson DM, Bäcklund LM, Ichimura K, et al: Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68:8673-8677, 2008
46. Judkins AR, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy SL, et al: INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol 64:391-397, 2005 (Pubitemid 40629129)
47. Kaplan AM, Albright AL, Zimmerman RA, Rorke LB, Li H, Boyett JM, et al: Brainstem gliomas in children. A Children's Cancer Group review of 119 cases. Pediatr Neurosurg 24:185-192, 1996 (Pubitemid 26258955)
48. Kieran MW, Supko JG, Wallace D, Fruscio R, Poussaint TY, Phillips P, et al: Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors. Pediatr Blood Cancer 52:169-176, 2009
49. Kim S, Salamon N, Jackson HA, Blüml S, Panigrahy A: PET imaging in pediatric neuroradiology: current and future applications. Pediatr Radiol 40:82-96, 2010
50. Kolb EA, Gorlick R, Houghton PJ, Morton CL, Neale G, Keir ST, et al: Initial testing (stage 1) of AZD6244 (ARRY-142886) by the pediatric preclinical testing program. Pediatr Blood Cancer 55:668-677, 2010
51. Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, et al: Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS ONE 3:e3088, 2008
52. Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, et al: Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy. Strahlenther Onkol 179:509-520, 2003 (Pubitemid 36966407)
53. Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, et al: Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity. Strahlenther Onkol 179:585-597, 2003 (Pubitemid 37101642)
54. Kretschmar CS, Tarbell NJ, Barnes PD, Krischer JP, Burger PC, Kun L: Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833. Cancer 72:1404-1413, 1993 (Pubitemid 23225016)
55. Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, et al: Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 363:1801-1811, 2010
56. Lafay-Cousin L, Holm S, Qaddoumi I, Nicolin G, Bartels U, Tabori U, et al: Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction. Cancer 103: 2636-2642, 2005 (Pubitemid 40800545)
57. Lam C, Bouffet E, Tabori U, Mabbott D, Taylor M, Bartels U: Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors. Pediatr Blood Cancer 54:476-479, 2010
58. Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C, et al: Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell 16:533-546, 2009
59. Lonser RR, Warren KE, Butman JA, Quezado Z, Robison RA, Walbridge S, et al: Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg 107:190-197, 2007 (Pubitemid 47026491)
60. MacDonald TJ, Arenson EB, Ater J, Sposto R, Bevan HE, Bruner J, et al: Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933. Cancer 104:2862-2871, 2005 (Pubitemid 41798299)
61. Massimino M, Spreafico F, Riva D, Biassoni V, Poggi G, Solero C, et al: A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma. J Neurooncol 100:65-71, 2010
62. Merchant TE, Jenkins JJ, Burger PC, Sanford RA, Sherwood SH, Jones-Wallace D, et al: Influence of tumor grade on time to progression after irradiation for localized ependymoma in children. Int J Radiat Oncol Biol Phys 53:52-57, 2002 (Pubitemid 34465807)
63. Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA: Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol 10:258-266, 2009
64. Merchant TE, Mulhern RK, Krasin MJ, Kun LE, Williams T, Li C, et al: Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 22:3156-3162, 2004 (Pubitemid 41103730)
65. Merchant TE, Zhu Y, Thompson SJ, Sontag MR, Heideman RL, Kun LE: Preliminary results from a Phase II trail of conformal radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma. Int J Radiat Oncol Biol Phys 52:325-332, 2002 (Pubitemid 34170841)
66. Milde T, Oehme I, Korshunov A, Kopp-Schneider A, Remke M, Northcott P, et al: HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth. Clin Cancer Res 16:3240-3252, 2010
67. Miralbell R, Fitzgerald TJ, Laurie F, Kessel S, Glicksman AS, Friedman HS, et al: Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031. Int J Radiat Oncol Biol Phys 64:1325-1330, 2006
68. Mishra KK, Squire S, Lamborn K, Banerjee A, Gupta N, Wara WM, et al: Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update. J Neurooncol 100:121-127, 2010
69. Moshel YA, Elliott RE, Monoky DJ, Wisoff JH: Role of diffusion tensor imaging in resection of thalamic juvenile pilocytic astrocytoma. Clinical article. J Neurosurg Pediatr 4:495-505, 2009
70. Moshel YA, Link MJ, Kelly PJ: Stereotactic volumetric resection of thalamic pilocytic astrocytomas. Neurosurgery 61:66-75, 2007 (Pubitemid 47356454)
71. Needle MN, Goldwein JW, Grass J, Cnaan A, Bergman I, Molloy P, et al: Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 80:341-347, 1997 (Pubitemid 27282329)
72. Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, Croul S, et al: Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 41:465-472, 2009
73. Okada H, Low KL, Kohanbash G, McDonald HA, Hamilton RL, Pollack IF: Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas. J Neurooncol 88:245-250, 2008
74. Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, et al: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747-754, 1997 (Pubitemid 27187674)
75. Packer RJ, Boyett JM, Zimmerman RA, Albright AL, Kaplan AM, Rorke LB, et al: Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial. Cancer 74:1827-1834, 1994 (Pubitemid 24301840)
76. Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al: Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24:4202-4208, 2006 (Pubitemid 46622300)
77. Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, et al: Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol 17:2127-2136, 1999 (Pubitemid 29318845)
78. Panigrahy A, Nelson MD Jr, Blüml S: Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. Pediatr Radiol 40:3-30, 2010
79. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al: An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812, 2008
80. Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, et al: The genetic landscape of the childhood cancer medulloblastoma. Science 331:435-439, 2011
81. Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, et al: Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28:3061-3068, 2010
82. Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, et al: BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 118:1739-1749, 2008 (Pubitemid 351632377)
83. Pirotte BJ, Lubansu A, Massager N, Wikler D, Goldman S, Levivier M: Results of positron emission tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors. J Neurosurg 107 (5 Suppl):392-399, 2007
84. Pizer BL, Weston CL, Robinson KJ, Ellison DW, Ironside J, Saran F, et al: Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCC-SG PNET 3 study. Eur J Cancer 42:1120-1128, 2006
85. Pollack IF: Brain tumors in children. N Engl J Med 331:1500-1507, 1994
86. Pollack IF: Posterior fossa syndrome. Int Rev Neurobiol 41:411-432, 1997
87. Pollack IF, Boyett JM, Yates AJ, Burger PC, Gilles FH, Davis RL, et al: The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience. Neuro Oncol 5:197-207, 2003 (Pubitemid 36790349)
88. Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M: Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg 82:536-547, 1995
89. Pollack IF, Finkelstein SD, Woods J, Burnham J, Holmes EJ, Hamilton RL, et al: Expression of p53 and prognosis in malignant gliomas in children. N Engl J Med 346:420-427, 2002 (Pubitemid 34437697)
90. Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shultz B, Albright AL, et al: Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 37:655-667, 1995
91. Pollack IF, Hamilton RL, James CD, Finkelstein SD, Burnham J, Yates AJ, et al: Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort. J Neurosurgery 105 (5 Suppl):418-424, 2006 (Pubitemid 44954773)
92. Pollack IF, Hamilton RL, Sobol RW, Burnham J, Yates AJ, Holmes EJ, et al: O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 cohort. J Clin Oncol 24:3431-3437, 2006 (Pubitemid 46638900)
93. Pollack IF, Hamilton RL, Sobol RW, Nikiforova MN, Lyons-Weiler MA, Laframboise WA, et al: IDH1 mutations are common in malignant gliomas arising in adolescence: a report from the Children's Oncology Group. Childs Nerv Syst 27:87-94, 2011
94. Pollack IF, Hoffman HJ, Humphreys RP, Becker L: The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 78:859-863, 1993 (Pubitemid 23159320)
95. Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, et al: Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol 9:145-160, 2007 (Pubitemid 46580316)
96. Pollack IF, Stewart CF, Kocak M, Poussaint TY, Broniscer A, Banerjee A, et al: A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol 13:290-297, 2011
97. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, et al: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442, 2002 (Pubitemid 34100955)
98. Radcliffe J, Packer RJ, Atkins TE, Bunin GR, Schut L, Goldwein JW, et al: Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy. Ann Neurol 32:551-554, 1992
99. Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, Fults DW, et al: Sporadic medulloblastomas contain PTCH mutations. Cancer Res 57:842-845, 1997 (Pubitemid 27098006)
100. Ridley L, Rahman R, Brundler MA, Ellison D, Lowe J, Robson K, et al: Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma. Neuro Oncol 10:675-689, 2008
101. Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer JR, et al: Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 88:695-703, 1998 (Pubitemid 28145213)
102. Romer J, Curran T: Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics. Cancer Res 65:4975-4978, 2005 (Pubitemid 40827300)
103. Roujeau T, Machado G, Garnett MR, Miquel C, Puget S, Geoerger B, et al: Stereotactic biopsy of diffuse pontine lesions in children. J Neurosurg 107 (1 Suppl):1-4, 2007
104. Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, et al: Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 361:1173-1178, 2009
105. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth- Metz M, Soerensen N, et al: Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978-986, 2005 (Pubitemid 40349500)
106. Spiller SE, Ravanpay AC, Hahn AW, Olson JM: Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. J Neurooncol 79:259-270, 2006 (Pubitemid 44363729)
107. Sposto R, Ertel IJ, Jenkin RD, Boesel CP, Venes JL, Ortega JA, et al: The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol 7:165-177, 1989 (Pubitemid 19182070)
108. Tabori U, Baskin B, Shago M, Alon N, Taylor MD, Ray PN, et al: Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations. J Clin Oncol 28:1345-1350, 2010
109. Tabori U, Ma J, Carter M, Zielenska M, Rutka J, Bouffet E, et al: Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma. J Clin Oncol 24:1522-1528, 2006 (Pubitemid 46638773)
110. Tait DM, Thornton-Jones H, Bloom HJG, Lemerle J, Morris-Jones P: Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26:464-469, 1990 (Pubitemid 20209976)
111. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, et al: Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8:323-335, 2005 (Pubitemid 41443417)
112. Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, et al: Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41:727-734, 2005 (Pubitemid 40342556)
113. Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, et al: Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23:1491-1499, 2005
114. Thomas PR, Deutsch M, Kepner JL, Boyett JM, Krischer J, Aronin P, et al: Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18:3004-3011, 2000 (Pubitemid 30644125)
115. Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, et al: Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24:1924-1931, 2006 (Pubitemid 46638992)
116. Ullrich NJ: Neurologic sequelae of brain tumors in children. J Child Neurol 24:1446-1454, 2009
117. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al: Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98-110, 2010
118. von Hoff K, Hartmann W, von Bueren AO, Gerber NU, Grotzer MA, Pietsch T, et al: Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors. Pediatr Blood Cancer 54:369-376, 2010
119. Warren KE, Goldman S, Pollack IF, Fangusaro J, Schaiquevich P, Stewart CF, et al: Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018. J Clin Oncol 29:324-329, 2011
120. Wells EM, Khademian ZP, Walsh KS, Vezina G, Sposto R, Keating RF, et al: Postoperative cerebellar mutism syndrome following treatment of medulloblastoma: neuroradiographic features and origin. Clinical article. J Neurosurg Pediatr 5:329-334, 2010
121. Wisoff JH, Sanford RA, Heier LA, Sposto R, Burger PC, Yates AJ, et al: Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children's Oncology Group. Neurosurgery 68:1548-1555, 2011
122. Yin D, Richardson RM, Fiandaca MS, Bringas J, Forsayeth J, Berger MS, et al: Cannula placement for effective convection- enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics. Laboratory investigation. J Neurosurg 113:240-248, 2010
123. Zarghooni M, Bartels U, Lee E, Buczkowicz P, Morrison A, Huang A, et al: Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol 28:1337-1344, 2010
124. Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, et al: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17:832-845, 1999 (Pubitemid 29109313)